These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9815240)

  • 1. Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants.
    van Rij RP; de Roda Husman AM; Brouwer M; Goudsmit J; Coutinho RA; Schuitemaker H
    J Infect Dis; 1998 Dec; 178(6):1806-11. PubMed ID: 9815240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
    Mulherin SA; O'Brien TR; Ioannidis JP; Goedert JJ; Buchbinder SP; Coutinho RA; Jamieson BD; Meyer L; Michael NL; Pantaleo G; Rizzardi GP; Schuitemaker H; Sheppard HW; Theodorou ID; Vlahov D; Rosenberg PS;
    AIDS; 2003 Feb; 17(3):377-87. PubMed ID: 12556692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression.
    de Roda Husman AM; van Rij RP; Blaak H; Broersen S; Schuitemaker H
    J Infect Dis; 1999 Oct; 180(4):1106-15. PubMed ID: 10479137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor function.
    Mariani R; Wong S; Mulder LC; Wilkinson DA; Reinhart AL; LaRosa G; Nibbs R; O'Brien TR; Michael NL; Connor RI; Macdonald M; Busch M; Koup RA; Landau NR
    J Virol; 1999 Mar; 73(3):2450-9. PubMed ID: 9971830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.
    Lathey JL; Tierney C; Chang SY; D'Aquila RT; Bettendorf DM; Alexander HC; Santini CD; Hughes AM; Barroga CF; Spector SA; Landes JE; Hammer SM; Katzenstein DA
    J Infect Dis; 2001 Dec; 184(11):1402-11. PubMed ID: 11709782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor polymorphisms and human immunodeficiency virus disease progression.
    Easterbrook PJ; Rostron T; Ives N; Troop M; Gazzard BG; Rowland-Jones SL
    J Infect Dis; 1999 Oct; 180(4):1096-105. PubMed ID: 10479136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
    Smith MW; Dean M; Carrington M; Winkler C; Huttley GA; Lomb DA; Goedert JJ; O'Brien TR; Jacobson LP; Kaslow R; Buchbinder S; Vittinghoff E; Vlahov D; Hoots K; Hilgartner MW; O'Brien SJ
    Science; 1997 Aug; 277(5328):959-65. PubMed ID: 9252328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.
    Ioannidis JP; Contopoulos-Ioannidis DG; Rosenberg PS; Goedert JJ; De Rossi A; Espanol T; Frenkel L; Mayaux MJ; Newell ML; Pahwa SG; Rousseau C; Scarlatti G; Sei S; Sen L; O'Brien TR;
    AIDS; 2003 Jul; 17(11):1631-8. PubMed ID: 12853745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global distribution of the CCR2-64I/CCR5-59653T HIV-1 disease-protective haplotype.
    Martinson JJ; Hong L; Karanicolas R; Moore JP; Kostrikis LG
    AIDS; 2000 Mar; 14(5):483-9. PubMed ID: 10780710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of CCR5 and CCR2 HIV-coreceptor gene polymorphisms in Belgium.
    Struyf F; Thoelen I; Charlier N; Keyaerts E; Van der Donck I; Wuu J; Van Ranst M
    Hum Hered; 2000; 50(5):304-7. PubMed ID: 10878474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.
    Tang J; Shelton B; Makhatadze NJ; Zhang Y; Schaen M; Louie LG; Goedert JJ; Seaberg EC; Margolick JB; Mellors J; Kaslow RA
    J Virol; 2002 Jan; 76(2):662-72. PubMed ID: 11752157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine receptor CCR2b 64I polymorphism and its relation to CD4 T-cell counts and disease progression in a Danish cohort of HIV-infected individuals. Copenhagen AIDS cohort.
    Eugen-Olsen J; Iversen AK; Benfield TL; Koppelhus U; Garred P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):110-6. PubMed ID: 9637575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population.
    Gharagozloo M; Doroudchi M; Farjadian S; Pezeshki AM; Ghaderi A
    Immunol Lett; 2005 Jan; 96(2):277-81. PubMed ID: 15585333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of CCR2-64I and not of CCR5-delta32 and SDF1-3'A in pediatric HIV-1 infection.
    Mangano A; Kopka J; Batalla M; Bologna R; Sen L
    J Acquir Immune Defic Syndr; 2000 Jan; 23(1):52-7. PubMed ID: 10708056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive effects of CCR5, CCR2, and SDF1 genetic polymorphisms in AIDS progression.
    Hendel H; Hénon N; Lebuanec H; Lachgar A; Poncelet H; Caillat-Zucman S; Winkler CA; Smith MW; Kenefic L; O'Brien S; Lu W; Andrieu JM; Zagury D; Schächter F; Rappaport J; Zagury JF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):381-6. PubMed ID: 9833747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variations in CC chemokine receptors and hypertension.
    Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
    Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypes and polymorphisms of mutant CCR5-delta 32, CCR2-64I and SDF1-3' a HIV-1 resistance alleles in indigenous Han Chinese.
    Wang F; Jin L; Lei Z; Shi H; Hong W; Xu D; Jiang J; Wang Y; Zhang B; Liu M; Li Y
    Chin Med J (Engl); 2001 Nov; 114(11):1162-6. PubMed ID: 11729511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of early detection of HIV type 1 SI/CXCR4-using viruses in vertically infected children.
    Crudeli CM; Aulicino PC; Rocco CA; Bologna R; Mangano A; Sen L
    AIDS Res Hum Retroviruses; 2012 Jul; 28(7):685-92. PubMed ID: 22023092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causal pathways of the effects of age and the CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on AIDS development.
    Geskus RB; Meyer L; Hubert JB; Schuitemaker H; Berkhout B; Rouzioux C; Theodorou ID; Delfraissy JF; Prins M; Coutinho RA
    J Acquir Immune Defic Syndr; 2005 Jul; 39(3):321-6. PubMed ID: 15980693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.